Feasibility and Pilot Studies Schemes
Feasibility and pilot studies are preparatory studies to demonstrate the feasibility of a larger study, including generating preliminary data. Such studies can include Phase II Clinical Trials which determine the most appropriate questions for the next generation of Phase III Clinical Trials. Phase II Clinical Trials aim to assess the activity, feasibility or toxicity of new treatment approaches, and can be used to screen out inactive treatments.
This scheme funds research in all types of biomarkers (predisposition, screening, diagnostic, prognostic, predictive, pharmacological and surrogate response) using invasive (i.e., surgical specimens or biofluids) and imaging technologies (i.e., MRI, CT, PET, SPECT, other nuclear medicine methods, ultrasound or optical).
More about Biomarkers & Imaging Discovery & Development Project Grants
Discovery Committee Grants scheme is the sole Cancer Research UK scheme operating for managed development of projects arising from its basic research portfolio. Also the scheme is responsible for Intellectual Property arising from outside the Cancer Research UK portfolio, but managed through Cancer Research Technology.
The Feasibility Study Project Grants scheme funds studies assessing the activity, feasibility or toxicity of new treatment approaches and can also be used to screen out inactive treatments.
The New Agents Committee (NAC) trials funding scheme provides a one-step process for selecting new anti-cancer treatments and diagnostics and taking them into early clinical trials.
Increase text
Decrease text
Print this page